A2LA Updates CMS-Approved Clinical Laboratory Accreditation Program

A2LA is proud to announce an update to its program for the accreditation of clinical laboratories performing waived testing. A2LA is approved by the Centers for Medicare and Medicaid Services (CMS) to accredit clinical laboratories (for all specialties and sub-specialties) to the requirements contained within the Clinical Laboratory Improvement Amendments (CLIA).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Frederick, MD (PRWEB) August 12, 2014

A2LA is proud to announce an update to its program for the accreditation of clinical laboratories performing waived testing. A2LA is approved by the Centers for Medicare and Medicaid Services (CMS) to accredit clinical laboratories (for all specialties and sub-specialties) to the requirements contained within the Clinical Laboratory Improvement Amendments (CLIA).

On August 7, 2014, CMS approved A2LA’s updated approach to accrediting laboratories that perform waived testing. Such testing will now be held to the CLIA waived testing requirements. A2LA has also chosen to adopt as requirements the guidelines published by the CDC (CS242576-A) related to waived testing. Although A2LA does not accredit laboratories that perform waived testing exclusively, those laboratories that perform non-waived testing in addition to waived testing are eligible for A2LA accreditation.

A2LA is the only U.S. accreditation body with dual recognitions in the clinical testing arena: Recognition by the International Laboratory Accreditation Cooperation (http://www.ILAC.org) for the accreditation of clinical laboratories to ISO 15189:2012 and recognition by CMS for the accreditation of clinical laboratories to the CLIA requirements. This results in a single accreditation that allows A2LA accredited clinical laboratories increased international business opportunities, improved quality and a clear competitive advantage.

Applicant clinical laboratories have the opportunity to implement A2LA’s “Platinum Choice” option that allows a clinical laboratory not only to meet CLIA requirements but also to gain accreditation to ISO 15189 with one assessment, using one team of assessors. The “Platinum Choice” option provides domestic recognition for accreditation to the CLIA requirements as well as international recognition of the clinical laboratory’s testing competence and quality via ISO 15189 accreditation. The CLIA and ISO 15189:2012 requirements work together to enhance the overall quality and to ensure patient health and welfare.

A2LA also offers a separate accreditation program to the CLIA requirements alone and an accreditation program to the ISO 15189:2012 requirements alone as additional options for clinical laboratories.

A2LA is the first CLIA accreditation organization to be recognized by CMS since 1995. For more information about A2LA’s exciting and innovative accreditation programs for clinical laboratories, please visit the A2LA website.

ABOUT A2LA:

A2LA is a CMS-approved, ILAC-recognized accreditation body with over 35 years of experience in accrediting laboratories in a multitude of fields. A2LA is the largest, multi-discipline accreditation body in the United States and has been operating as a non-profit, public service, membership society since 1978. A2LA offers accreditation to ISO 15189:2012 and to the CLIA requirements for clinical testing laboratories and also offers a variety of public and private training courses relevant to the clinical testing community.


Contact